Breaking News & Top Stories
A groundbreaking sensor has been developed to accurately assess fish freshness, offering a more reliable method than traditional visual and olfactory checks. This innovation enables consumers and businesses in the…
Paradromics, a brain-computer interface startup based in Austin, Texas, has received approval from the Food and Drug Administration (FDA) to conduct a human trial aimed at restoring speech in individuals…
Recent research from the University of Minnesota Medical School reveals that innovative molecules, referred to as “molecular bumpers” and “molecular glues,” can significantly reshape the signaling of G protein-coupled receptors…
The Food and Drug Administration (FDA) has expanded a recall of ground cinnamon after discovering elevated levels of lead in products from several brands. The recall now includes cinnamon from…
The US Supreme Court has chosen not to engage in a significant legal dispute regarding the Food and Drug Administration’s (FDA) power to regulate unproven stem cell treatments. On October…
The Food and Drug Administration (FDA) has announced a Class II recall of over 54,000 bottles of a widely prescribed thyroid medication due to concerns over low potency. The recall…
Federal authorities have confiscated more than 2.1 million unauthorized flavored e-cigarettes in a significant operation targeting illegal vaping products. The U.S. Department of Justice (DOJ) announced the seizures this week,…
The life sciences sector remains one of the most regulated industries globally, impacting how products like cancer therapies and medical devices reach the market. Startups, lawyers, and investors must understand…
New York Governor Kathy Hochul has issued an executive order expanding access to COVID-19 vaccines for all residents. This directive allows New Yorkers to receive vaccinations at local pharmacies, a…
On August 22, 2025, the U.S. Food and Drug Administration (FDA) announced the suspension of the biologics license for the chikungunya vaccine Ixchiq, developed by Valneva Austria GmbH. This decision…